Home › Cancro pancreatico › Virginia › Arlington
Studi clinici su Cancro pancreatico a Arlington, VA
33 studi su Cancro pancreatico cercano partecipanti presso sedi a Arlington e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
The Vanguard Study: Testing a New Way to Screen for Cancer
In reclutamentoVolontari sani benvenuti
- Inova Schar Cancer Institute, Fairfax · a 11 mi di distanza
- Inova Fair Oaks Hospital, Fairfax · a 11 mi di distanza
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
In reclutamentoFase 3
- Virginia Cancer Specialists, Fairfax · a 11 mi di distanza
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
In reclutamentoFase 1/2
- NEXT Virginia, Fairfax · a 11 mi di distanza
A Study of PHN-012 in Patients With Advanced Solid Tumors
In reclutamentoFase 1
- PHN-012-001 Site, Fairfax · a 11 mi di distanza
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
In reclutamentoFase 1
- NEXT Oncology Virginia, Fairfax · a 11 mi di distanza
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
In reclutamentoFase 3
- Virginia Cancer Specialists, Fairfax · a 11 mi di distanza
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
In reclutamentoFase 3
- Investigative Site US057, Fairfax · a 11 mi di distanza
- Investigative Site US065, Fairfax · a 11 mi di distanza
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
In reclutamentoFase 3
- Inova Schar Cancer Institute Clinical Trials, Fairfax · a 11 mi di distanza
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
In reclutamentoFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi di distanza
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
In reclutamentoFase 1/2
- NEXT Oncology Virginia, Fairfax · a 11 mi di distanza
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
In reclutamentoFase 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · a 11 mi di distanza
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
In reclutamentoFase 1
- NEXT - Virginia, Fairfax · a 11 mi di distanza
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
In reclutamentoFase 1
- NEXT Oncology, Fairfax · a 11 mi di distanza
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
In reclutamentoStudio osservazionale
- Inova Fairfax Hospital, Falls Church · a 4 mi di distanza
- Inova Schar Cancer Institute, Fairfax · a 11 mi di distanza
- Inova Fair Oaks Hospital, Fairfax · a 11 mi di distanza
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
In reclutamentoFase 2
- Virginia Cancer Specialists, Fairfax · a 11 mi di distanza
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
In reclutamentoFase 1
- Virginia Cancer Specialists, PC, Fairfax · a 11 mi di distanza
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
In reclutamentoFase 3
- Inova Fairfax Hospital, Falls Church · a 4 mi di distanza
- Inova Schar Cancer Institute, Fairfax · a 11 mi di distanza
- Inova Fair Oaks Hospital, Fairfax · a 11 mi di distanza
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
In reclutamentoFase 1
- NEXT Virginia, Fairfax · a 11 mi di distanza
Pancreatic Cancer Early Detection Consortium
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Inova Schar Cancer Institute, Fairfax · a 11 mi di distanza
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
In reclutamentoFase 1
- NEXT Virginia, Fairfax · a 11 mi di distanza
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
In reclutamentoFase 1
- NEXT Virginia, Fairfax · a 11 mi di distanza
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
In reclutamentoFase 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · a 11 mi di distanza
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
In reclutamentoFase 1
- Research Site, Fairfax · a 11 mi di distanza
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
In reclutamentoFase 1
- NEXT Oncology Virginia, Fairfax · a 11 mi di distanza
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
In reclutamentoFase 1/2
- NEXT Virginia, Fairfax · a 11 mi di distanza
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
In reclutamentoFase 3
- Inova Schar Cancer Institute, Fairfax · a 11 mi di distanza
- Inova Fair Oaks Hospital, Fairfax · a 11 mi di distanza
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
In reclutamentoFase 1/2
- Next Oncology Virginia, Fairfax · a 11 mi di distanza
A 2-part Phase 1/2 Open-label Trial on ODM-212
In reclutamentoFase 1/2
- NEXT Oncology Virginia, Fairfax · a 11 mi di distanza
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
In reclutamentoFase 1/2
- NEXT Virginia, Fairfax · a 11 mi di distanza
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
In reclutamentoFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi di distanza
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
In reclutamentoFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi di distanza
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- NEXT Virginia, Fairfax · a 11 mi di distanza
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
In reclutamentoFase 1/2
- NEXT, Virginia, Fairfax · a 11 mi di distanza
Studi su Cancro pancreatico in altre città
- Houston, TX61 studi
- New York City, NY60 studi
- Boston, MA43 studi
- Nashville, TN39 studi
- Los Angeles, CA35 studi
- St. Louis, MO33 studi
- Baltimore, MD31 studi
- San Antonio, TX31 studi
- Philadelphia, PA26 studi
- Tampa, FL26 studi
- Durham, NC24 studi
- San Diego, CA24 studi
Altri studi a Arlington
- Cancro del polmone non a piccole cellule104 studi
- Cancro metastatico53 studi
- Cancro colorettale52 studi
- Cancro (tutti i tipi)48 studi
- Cancro al seno47 studi
- Cancro ovarico46 studi
- Cancro ai polmoni41 studi
- Cancro dell'endometrio39 studi
- Carcinoma a cellule squamose della testa e del collo26 studi
- Carcinoma polmonare a piccole cellule23 studi
- Cancro dello stomaco20 studi
- Cancro al seno triplo negativo20 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.